Antimicrobial-impregnated wound dressings, particularly silver and iodine-based products, have become a routine part of many wound care formularies. Growing awareness of topical antimicrobial resistance risk, paralleling the broader antibiotic stewardship movement, is pushing wound care programs to apply the same disciplined, evidence-based use criteria to these products rather than defaulting to antimicrobial dressings for any wound with even modest infection concern.
Why Stewardship Matters Here Too
Overuse of antimicrobial dressings on wounds without genuine infection or high infection risk contributes to resistance pressure and adds unnecessary cost, without providing meaningful clinical benefit over standard dressings for wounds that don't actually need antimicrobial support. The parallel to systemic antibiotic overuse is increasingly explicit in wound care stewardship guidance.
Building Appropriate Use Criteria
- Clear clinical indication criteria defining which wound presentations genuinely warrant antimicrobial dressing use, rather than leaving the decision to individual clinician discretion without guidance
- Defined treatment duration limits, since continuing antimicrobial dressing use well past the point of clinical benefit is a common stewardship gap
- Reassessment triggers prompting a switch back to standard dressings once infection signs resolve, rather than continuing antimicrobial treatment by default
The Cost Dimension
Beyond the resistance concern, antimicrobial dressings carry a meaningful cost premium over standard dressings, making stewardship a genuine cost management lever alongside its clinical and public health rationale — a combination that tends to make the business case for a formal stewardship program relatively easy to build.
Facilities building wound care stewardship programs can review Healix Medical Supply's wound care catalog.
